Home LiteratureArticle Details
PMID: 11119580 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Alteration of zinc-binding residues of simian immunodeficiency virus p8(NC) results in subtle differences in gag processing and virion maturation associated with degradative loss of mutant NC.

Journal of virology ·Vol. 75 ·No. 1 ·2001-01-00 ·Pages 115-24

Yovandich JL, Chertova EN, Kane BP, Gagliardi TD, Bess JW, Sowder RC, Henderson LE, Gorelick RJ

Abstract

In all retroviruses analyzed to date (except for the spumaretroviruses), the Zn(2+)-coordinating residues of nucleocapsid (NC) perform or assist in crucial reactions necessary to complete the retrovirus life cycle. Six replication-defective mutations have been engineered in the two NC Zn(2+) fingers (ZFs) of simian immunodeficiency virus [SIV(Mne)] that change or delete specific Zn(2+)-interacting Cys residues and were studied by using electron microscopy, reversed-phase high-performance liquid chromatography, immunoblotting, and RNA quantification. We focused on phenotypes of produced particles, specifically morphology, Gag polyprotein processing, and genomic RNA packaging. Phenotypes were similar among viruses containing a point or deletion mutation involving the same ZF. Mutations in the proximal ZF (ZF1) resulted in near-normal Gag processing and full-length genomic RNA incorporation and were most similar to wild-type (WT) virions with electron-dense, conical cores. Mutation of the distal ZF, as well as point mutations in both ZFs, resulted in more unprocessed Gag proteins than a deletion or point mutation in ZF1, with an approximate 30% reduction in levels of full-length genomic RNA in virions. These mutant virions contained condensed cores; however, the cores typically appeared less electron dense and more rod shaped than WT virions. Surprisingly, deletion of both ZFs, including the basic linker region between the ZFs, resulted in the most efficient Gag processing. However, genomic RNA packaging was approximately 10% of WT levels, and those particles produced were highly abnormal with respect to size and core morphology. Surprisingly, all NC mutations analyzed demonstrated a significant loss of processed NC in virus particles, suggesting that Zn(2+)-coordinated NC is protected from excessive proteolytic cleavage. Together, these results indicate that Zn(2+) coordination is important for correct Gag precursor processing and NC protein stability. Additionally, SIV particle morphology appears to be the result of proper and complete Gag processing and relies less on full-length genomic RNA incorporation, as dictated by the Zn(2+) coordination in the ZFs of the NC protein.

MeSH Terms
Amino Acid Sequence Animals Chromatography, High Pressure Liquid Gene Products, gag/metabolism Molecular Sequence Data Nucleocapsid/chemistry,physiology Simian Immunodeficiency Virus/physiology Structure-Activity Relationship Terminal Repeat Sequences Virion/physiology Zinc/metabolism
Chemicals
Gene Products, gag Zinc
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Yovandich J L
AIDS Vaccine Program, SAIC-Frederick, National Cancer Institute, Frederick, Maryland 21702-1201, USA.
Chertova E N
Kane B P
Gagliardi T D
Bess J W
Sowder R C
Henderson L E
Gorelick R J
References (51)
51 references, click to expand
  1. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA.
    J Virol. 1990 Jul;64(7):3207-11 PMID: 2191147
  2. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease.
    AIDS Res Hum Retroviruses. 1989 Dec;5(6):577-91 PMID: 2692658
  3. In situ processing of a retroviral nucleocapsid protein by the viral proteinase.
    Protein Eng. 1991 Aug;4(6):695-700 PMID: 1658777
  4. Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type I, and other retroviruses.
    J Virol. 1992 Feb;66(2):840-7 PMID: 1731111
  5. Effect of rearrangements and duplications of the Cys-His motifs of Rous sarcoma virus nucleocapsid protein.
    J Virol. 1993 Feb;67(2):623-31 PMID: 8380458
  6. Studies on the substrate specificity of the proteinase of equine infectious anemia virus using oligopeptide substrates.
    Biochemistry. 1993 Apr 6;32(13):3347-53 PMID: 8384879
  7. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent.
    J Virol. 1993 Jul;67(7):4027-36 PMID: 8510214
  8. Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues.
    EMBO J. 1994 Apr 1;13(7):1525-33 PMID: 8156990
  9. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis.
    J Virol. 1994 Aug;68(8):4927-36 PMID: 8035491
  10. Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus.
    J Virol. 1994 Sep;68(9):6124-9 PMID: 8057495
  11. Removal of zinc is required for processing of the mature nucleocapsid protein of human immunodeficiency virus, type 1, by the viral protease.
    J Biol Chem. 1994 Sep 2;269(35):21948-50 PMID: 8071314
  12. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.
    J Virol. 1994 Dec;68(12):8017-27 PMID: 7966591
  13. Functional domains of the capsid protein of human immunodeficiency virus type 1.
    J Virol. 1994 Dec;68(12):8180-7 PMID: 7966609
  14. The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity.
    J Virol. 1995 Mar;69(3):1778-84 PMID: 7853517
  15. Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus.
    J Virol. 1995 May;69(5):3117-24 PMID: 7707540
  16. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity.
    J Virol. 1995 Jun;69(6):3407-19 PMID: 7745687
  17. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.
    J Virol. 1995 Oct;69(10):6487-97 PMID: 7666550
  18. Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA.
    J Virol. 1996 Apr;70(4):2593-7 PMID: 8642691
  19. Mutational analysis of two zinc finger motifs in HIV type 1 nucleocapsid proteins: effects on proteolytic processing of Gag precursors and particle formation.
    AIDS Res Hum Retroviruses. 1996 Jun 10;12(9):793-800 PMID: 8738431
  20. RNA packaging.
    Curr Top Microbiol Immunol. 1996;214:177-218 PMID: 8791728
  21. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity.
    J Virol. 1996 Oct;70(10):6607-16 PMID: 8794295
  22. Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis.
    J Virol. 1997 Sep;71(9):6973-81 PMID: 9261426
  23. Distinct functions and requirements for the Cys-His boxes of the human immunodeficiency virus type 1 nucleocapsid protein during RNA encapsidation and replication.
    J Virol. 1997 Dec;71(12):9295-305 PMID: 9371588
  24. A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.
    J Virol. 1998 Mar;72(3):2072-8 PMID: 9499062
  25. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly.
    EMBO J. 1998 Mar 16;17(6):1555-68 PMID: 9501077
  26. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.
    J Virol. 1998 Apr;72(4):2846-54 PMID: 9525604
  27. Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication.
    J Virol. 1998 May;72(5):4442-7 PMID: 9557738
  28. Particle size determinants in the human immunodeficiency virus type 1 Gag protein.
    J Virol. 1998 Jun;72(6):4667-77 PMID: 9573230
  29. Morphopoietic determinants of HIV-1 Gag particles assembled in baculovirus-infected cells.
    Virology. 1998 Aug 1;247(2):160-9 PMID: 9705909
  30. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.
    J Virol. 1998 Oct;72(10):7992-8001 PMID: 9733838
  31. HIV-1: fifteen proteins and an RNA.
    Annu Rev Biochem. 1998;67:1-25 PMID: 9759480
  32. Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue.
    J Virol. 1998 Nov;72(11):9034-44 PMID: 9765448
  33. Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine.
    AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S311-9 PMID: 9814959
  34. HIV-1 gag proteins: diverse functions in the virus life cycle.
    Virology. 1998 Nov 10;251(1):1-15 PMID: 9813197
  35. The role of nucleocapsid of HIV-1 in virus assembly.
    Virology. 1998 Nov 10;251(1):141-57 PMID: 9813210
  36. Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein.
    J Virol. 1999 Jan;73(1):19-28 PMID: 9847302
  37. Assembly and analysis of conical models for the HIV-1 core.
    Science. 1999 Jan 1;283(5398):80-3 PMID: 9872746
  38. Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo.
    Virology. 1999 Jan 20;253(2):259-70 PMID: 9918884
  39. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences.
    Virology. 1999 Mar 30;256(1):92-104 PMID: 10087230
  40. Protection from pathogenic SIV challenge using multigenic DNA vaccines.
    Immunol Lett. 1999 Mar;66(1-3):183-8 PMID: 10203053
  41. Deletion mutagenesis within the dimerization initiation site of human immunodeficiency virus type 1 results in delayed processing of the p2 peptide from precursor proteins.
    J Virol. 1999 Jul;73(7):6147-51 PMID: 10364374
  42. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.
    J Virol. 1999 Sep;73(9):7524-32 PMID: 10438842
  43. Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques.
    J Virol. 1999 Oct;73(10):8201-15 PMID: 10482571
  44. Multiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication.
    J Virol. 1999 Dec;73(12):10000-9 PMID: 10559314
  45. A conformational switch controlling HIV-1 morphogenesis.
    EMBO J. 2000 Jan 4;19(1):103-13 PMID: 10619849
  46. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1.
    J Virol. 2000 Feb;74(3):1168-77 PMID: 10627527
  47. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.
    J Virol. 2000 Apr;74(7):3046-57 PMID: 10708419
  48. Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions.
    J Virol. 2000 Nov;74(22):10514-22 PMID: 11044096
  49. Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses.
    J Virol. 1986 Nov;60(2):483-90 PMID: 3021982
  50. Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne).
    J Virol. 1988 Aug;62(8):2587-95 PMID: 3292789
  51. Point mutations in the proximal Cys-His box of Rous sarcoma virus nucleocapsid protein.
    J Virol. 1990 Oct;64(10):4978-87 PMID: 2168981
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2001-01-00
Pages
115-24
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC113904
Subset
IM
Grants
NCI NIH HHS · N01-CO-56000 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com